Comparative Genomic Hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma

International Journal of Oncology

Volumn 14, Issue 6, 1999, Pages 1157-1162

  Komoike, Yoshifumi ^a   Tamaki, Yasuhiro ^a   Sakita, Isao ^a   Tomita, Naohiro ^a   Ohue, Masayuki ^a   Sekimoto, Mitsugu ^a   Miyazaki, Michihiko ^a   Kadota, Masao ^a   Masuda, Norikazu ^a   Ooka, Masaru ^a   Ohnishi, Tadashi ^a   Nakano, Yoshiaki ^a   Kozaki, Takazumi ^b   Kobayashi, Tetsuro ^c   Matsuura, Nariaki ^d   Ikeda, Takayuki ^e   Horii, Akira ^e   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b SRL INC   (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anaplastic thyroid cancer; Comparative genomic hybridization; Genomic imbalance

Indexed keywords

ARTICLE; CARCINOMA; CELL CULTURE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CHROMOSOME 16; COMPARATIVE STUDY; FLUORESCENCE MICROSCOPY; GENE DELETION; GENETICS; HETEROZYGOSITY LOSS; HUMAN; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; THYROID TUMOR;

CARCINOMA; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 16; GENE DELETION; HUMANS; LOSS OF HETEROZYGOSITY; MICROSCOPY, FLUORESCENCE; NUCLEIC ACID HYBRIDIZATION; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033146620     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.6.1157     Document Type: Review

References (29)

1. Venkatesh YSS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H and Samaan NA: Anaplastic carcinoma of the thyroid. Cancer 66: 321-330, 1990.
2. Rosai J and Carcangiu ML: Pathology of thyroid tumors. Some recent and old questions. Hum Pathol 15: 1008-1012, 1984.
3. Nakamura T, Yana I, Kobayashi T, Shin E, Karakawa K, Fujita S, Miya A, Mori T, Nishisho I and Takai S: p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas. Jpn J Cancer Res 83: 1293-1298, 1992.
4. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992.
5. Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B and Thomas WD: High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 4: 159-164, 1989.
6. Grieco M, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Porta GD, Fusco A and Vecchio G: PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60: 557-563, 1990.
7. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A and Ponder BAJ: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458-460, 1993.
8. Frank-Raue K, Hoppner W, Buhr H, Herfarth CH, Ziegler R and Raue F: Application of genetic screening in families with hereditary medullary thyroid carcinoma. Exp Clin Endocrinol Diabetes 104 (Suppl 4): 108-110, 1996.
9. Paredes-Zaglul A, Kang JJ, Essig Y-P, Mao W, Irby R, Wloch M and Yeatman TJ: Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes. Clin Cancer Res 4: 879-886, 1998.
10. Courjal F and Theillet C: Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res 57: 4368-4377, 1997.
11. Iwabuchi H, Sakamoto M, Sakunaga H, Ma Y-Y, Carcangiu ML, Pinkel D, Yang-Feng TL and Gray JW: Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 55: 6172-6180, 1995.
12. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A and Dejean A: Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 18: 59-65, 1997.
13. Suzuki K, Ogura T, Yokose T, Nagai K, Mukai K, Kodama T, Nishiwaki Y and Esumi H: Loss of heterozygosity in the tuberous sclesosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia. Int J Cancer 79: 384-389, 1998.
14. Nagai H, Pineau P, Tiollais P, Buendia MA and Dejean A: Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 14: 2927-2933, 1997.
15. Joos S, Bergerheim US, Pan Y, Matsuyama H, Bentz M, Du Manoir S and Lichter P: Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 14: 267-276, 1995.
16. Al-Gehani RM, Povey S, Delhanty JD and Parrington JM: Loss of heterozygosity on chromosome arms 5q, 11p, 11q, 13q, and 16p in human testicular germ cell tumors. Genes Chromosomes Cancer 13: 249-256, 1995.
17. Takei K, Kohno T, Hamada K, Takita J, Noguchi M, Matsuo Y, Hirohashi S, Uezato H and Yokota J: A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer. Cancer Res 58: 3700-3705, 1998.
18. Martinez LE, Abad A, Font A, Monzo M, Ojangueren I, Pifarre A, Sanchez JJ, Martin C and Rosell R: Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 114: 1180-1187, 1998.
19. Huiping C, Eiriksdottir G, Sigurdsson A, Sigurgeirsdottir JR, Barkardottir RB, Egilsson V and Ingvarsson S: High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content. Anticancer Res 18: 1031-1036, 1998.
20. Inoue T, Uchino S, Shiraishi N, Adachi Y and Kitano S: Loss of heterozygosity on chromosome 18q in cohensive-type gastric cancer is associated with tumor progression and poor prognosis. Clin Cancer Res 4: 973-977, 1998.
21. Pearlstein RP, Benninger MS, Carey TE, Zarbo RJ, Torres FX, Rybicki BA and Dyke DL: Loss of 18q predicts poor survival of patients with squamous cell of the head and neck. Genes Chromosomes Cancer 21: 333-339, 1998.
22. Ueda T, Komiya A, Emi M, Suzuki H, Shiraishi T, Yatani R, Masai M, Yasuda K and Ito H: Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancer. Genes Chromosomes Cancer 20: 140-147, 1997.
23. Frank CJ, McClatchey KD, Devaney KO and Carey TE: Evidence that loss of chromosome 18q is associated with tumor progression. Cancer Res 57: 824-827, 1997.
24. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW and Waldman FM: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91: 2156-2160, 1994.
25. Yeager TR, De Vries S, Jarrard DF, Kao C, Nakada SY, Moon TD, Bruskewitz R, Stadler WM, Meisner LF, Gilchrist KW, Newton MA, Waldman FM and Reznikoff CA: Overcoming cellular senescence in human cancer pathogenesis. Genes Dev 12: 163-174, 1998.
26. Fukushige S, Waldman FM, Kimura M, Abe T, Furukawa T, Sunamura M, Kobari M and Horii A: Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 19: 161-169, 1997.
27. Savelieva E, Belair CD, Newton MA, De Vries S, Gray JW, Waldman F and Reznikoff CA: 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Oncogene 14: 551-560, 1997.
28. Nakao K, Shibusawa M, Tsunoda A, Yoshizawa H, Murakami M, Kusano M, Uesugi N and Sasaki K: Genetic changes in primary colorectal cancer by comparative genomic hybridization. Surg Today 28: 567-569, 1998.
29. Mahlamaki EH, Hoglund M, Gorunova L, Karhu R, Dawiskiba S, Andren-Sandberg A, Kallioniemi OP and Johansson B: Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12q, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer 20: 383-391, 1997.